Did you know that the knee is the most commonly affected joint in osteoarthritis (OA)? According to the World Health Organization, knee OA affects a staggering 365 million people worldwide, followed closely by OA in the hip and hand. This underscores the vast impact of this degenerative joint disease on quality of life for so many.
For those with knee OA, conservative therapies like physical therapy, pain medications, and lifestyle adjustments are often the first line of defense. But when these options fail to bring relief, patients frequently seek alternative solutions for their chronic pain and restricted mobility. Fortunately, viscosupplementation therapies such as Cingal injections offer hope for symptom relief in cases where standard treatments fall short.
In this article, we’ll explore how Cingal works, review expert perspectives and patient experiences, and examine its effectiveness in addressing knee osteoarthritis symptoms.
Key Takeaways
- When administered by a qualified medical professional, Cingal replenishes lost hyaluronic acid in the joint’s synovial fluid, restoring its viscoelastic properties.
- Cingal offers a single injection treatment, combining the benefits of both a corticosteroid and hyaluronic acid in its unique formulation.
- After trying various viscosupplements, a patient praised Cingal injections after they experienced immediate and long-lasting relief that they were unable to find with their previous treatments.
- Five knee OA patients who received Cingal experienced immediate relief, and they were all able to resume their daily activities without an extended period of recovery.
About: Medica Depot is your trusted all-in-one supplier, offering a range of high-quality medical injectables and supplies. Buy Cingal online at Medica Depot today! Whether for health professionals, plastic surgeons, dermatologists, licensed estheticians, or other specialists, we can offer genuine, brand-name products you may need. With Medica Depot, we prioritize serving you better to improve the patient’s quality of life.
What is Cingal and How Does it Work?
Anika Therapeutics developed Cingal injections as a next-generation treatment specifically targeting knee osteoarthritis (OA). Cingal is unique for combining a corticosteroid with a hyaluronic acid-based formula in a single injection, offering dual benefits to patients. The hyaluronic acid component provides crucial lubrication and cushioning, helping to restore joint function, while the corticosteroid delivers rapid pain relief by reducing inflammation.
When administered by a qualified professional, Cingal replenishes lost hyaluronic acid in the joint’s synovial fluid and restores its viscoelastic properties, enhancing overall joint function and relieving symptoms. The corticosteroid acts specifically on the inflamed areas to manage pain caused by cartilage friction.
Practitioners often compare Cingal vs Durolane, but Cingal’s unique combination approach offers superior relief and functional improvement for many. Although designed primarily for knee OA, some medical professionals also consider Cingal hip injections for patients dealing with hip osteoarthritis, expanding its utility to other joint areas.
Patient Testimonials
Many patients have noted substantial improvements in mobility and pain relief following their Cingal injection treatments. However, limited patient testimonials have been shown online, highlighting their positive experience treating their knee osteoarthritis (OA) condition and approving the product’s efficacy in delivering symptomatic relief.
This patient has experienced various sports-related injuries that soon resulted in knee osteoarthritis. While they have tried many viscosupplements, their Cingal experience brought them instant relief post-injection, allowing them to return to their usual activities or hobbies.
Additionally, several studies have showcased that Cingal injections have significantly alleviated joint pain and improved function. In week 1 post-treatment, patients experienced an average of 59% reduction in pain, which increased to 72% at week 26. 89% of these patients responded positively with Cingal regarding pain, stiffness, and joint function in week 1.
By week 26, 92% of the patients had felt and sustained symptomatic relief from Cingal injection treatment. Unfortunately, Cingal has limited data and studies on overall satisfaction rates and treatment outcomes. It’s worth noting that results may vary, requiring a patient-centric approach from qualified medical professionals.
Practitioner Perspectives
In addition to the patient testimonials, medical practitioners have shared their experiences and feedback after administering Cingal injections for knee osteoarthritis (OA). This experienced doctor injected Cingal into five knee OA patients, each receiving immediate relief and allowing them to return to their daily activities.
Another medical practitioner administered a Cingal injection to a 45-year-old undergoing an addiction treatment. While the patient’s surgeon highly advised them to be drug-free before undergoing a knee replacement surgery, Cingal injections immensely helped in addressing limited mobility and other related symptoms.
Clinical evidence from Cingal showed that the viscosupplement outperformed a leading single-injection HA viscosupplement in weeks one and three, showcasing the corticosteroid’s early pain relief benefits. It also affirms the safety and efficacy of a single intra-articular Cingal injection, providing rapid and sustained relief from joint pain and symptoms in knee osteoarthritis patients.
Patients seeking a non-surgical solution for osteoarthritis pain relief should consider Cingal, especially for quick and long-term benefits. However, it’s essential to consult a healthcare provider to determine patient suitability and create a tailored treatment plan for maximum benefits and safety. They should also explain potential Cingal side effects and compare it to other viscosupplements.
Conclusion
Cingal injections represent an innovative option for individuals suffering from knee osteoarthritis. They offer effective relief through a unique combination of hyaluronic acid and corticosteroid. Many patients and practitioners report significant improvements in pain, inflammation, and mobility, contributing to a better overall quality of life.
However, it’s essential to remember that individual results may vary, and further research will help to deepen our understanding of Cingal’s long-term effectiveness. Consulting with a qualified healthcare provider can help patients determine whether Cingal injections are the right choice for their specific needs.
FAQs
1. What is Cingal, and how does it work for knee osteoarthritis?
Cingal is a next-generation viscosupplement developed to treat knee osteoarthritis. It combines hyaluronic acid, which provides lubrication and cushioning, with a corticosteroid that reduces inflammation. This dual action helps alleviate pain and improve joint function.
2. What have patients experienced after receiving Cingal injections?
Many patients report significant improvements in mobility and pain relief after Cingal injections. Studies indicate that patients experienced an average pain reduction of 59% at one-week post-treatment, with 92% maintaining relief by week 26.
3. Are there any practitioner endorsements for Cingal injections?
Yes, medical professionals have noted positive outcomes when administering Cingal. In clinical observations, patients often experience immediate relief, allowing them to return to their daily activities effectively and safely.
References
- World Health Organization. (2023, July 14). Osteoarthritis. Www.who.int; World Health Organization. https://www.who.int/news-room/fact-sheets/detail/osteoarthritis
- The Patient Experience | Pain Relief for Knee Osteoarthritis. (n.d.). Cingal. Retrieved November 4, 2024, from https://www.cingal.com/the-patient-experience/overview/
